Januvia is a popular Type 2 diabetes drug that helps the body increase insulin production when blood sugar levels are high and reduces the amount of sugar made by the liver when the body does not need it.
Januvia is one of the first dipeptidyl peptidase-4 (DPP-IV) inhibitors on the market. Released by Merck & Co. in 2006, the drug dominated sales and accounted for about 80 percent of worldwide sales for single-compound products. Januvia made up for more than 60 percent of the DPP-IV market.
Januvia® Pancreatic Cancer Side Effects
Despite the drug’s widespread use, Januvia is linked to serious side effects. A study at the Larry L. Hillbom Islet Research Center at the University of California found that people taking certain diabetes medications have more than a two-fold increase in pancreatic cancer diagnoses.
If you or a loved one were diagnosed with pancreatic cancer after taking Januvia, you may be entitled to significant financial compensation for your medical bills, pain and suffering, lost wages, and more. The experienced drug injury lawyers at Cory Watson Attorneys can help determine if you are eligible to file a Januvia lawsuit.
Call (877) 562-0000 or complete our free initial consultation form for a no-cost, no-obligation review of your Januvia claim today. We’re available 24/7, and the information you share with us is completely confidential.
Contact our Januvia® Attorneys Today
You deserve compensation if your injuries are the result of a pharmaceutical company’s negligence. At Cory Watson Attorneys, we’ve recovered more than $2.7 billion for injury victims across the country, and we want to put our experience to work for you.
From our main office in Birmingham, Alabama, we represent clients throughout the United States. Call (877) 562-0000 or complete our free initial consultation form to schedule your FREE initial case consultation today.
Januvia® is a registered trademark of Merck & Co., Inc., and is used here only to identify the product in question.
This law firm is not associated with, sponsored by, or affiliated with Merck & Co., Inc.; The University of California, Los Angeles; or the U.S. Food and Drug Administration.